+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Duodenal Ulcer Drug"

Duodenal Ulcer Treatment Market Report 2024 - Product Thumbnail Image

Duodenal Ulcer Treatment Market Report 2024

  • Report
  • September 2024
  • 175 Pages
  • Global
From
From
Duodenal Ulcer - Pipeline Insight, 2024 - Product Thumbnail Image

Duodenal Ulcer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
  • 6 Results (Page 1 of 1)
Loading Indicator

The Duodenal Ulcer Drug market is a subset of the Gastrointestinal Drugs market, which includes drugs used to treat diseases and disorders of the digestive system. Duodenal Ulcer Drugs are used to treat duodenal ulcers, which are sores that form in the lining of the duodenum, the first part of the small intestine. These drugs work by reducing the amount of acid produced in the stomach, which helps to reduce pain and promote healing. Commonly prescribed drugs include proton pump inhibitors, H2 blockers, and antibiotics. Some companies in the Duodenal Ulcer Drug market include AstraZeneca, Pfizer, Takeda Pharmaceuticals, and GlaxoSmithKline. Show Less Read more